(Q42663567)

4 November 2017

Investigation of the relationship between vitamin D and bone mineral density in newly diagnosed multiple sclerosis (English)

1 reference

4 November 2017

0 references

0 references

2

Serkan Kirbas

1 reference

4 November 2017

Aynur Kirbas

1

1 reference

4 November 2017

Omer Anlar

3

1 reference

4 November 2017

Aysegul Kucukali Turkyilmaz

4

1 reference

4 November 2017

Medine Cumhur Cure

5

1 reference

4 November 2017

Hasan Efe

6

1 reference

4 November 2017

16 August 2012

1 reference

4 November 2017

Acta Neurologica Belgica

1 reference

4 November 2017

113

1 reference

4 November 2017

1

1 reference

4 November 2017

43-47

1 reference

https://scigraph.springernature.com/pub.10.1007/s13760-012-0123-0

4 November 2017

0 references

cites work

Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0123-0

Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0123-0

Multiple sclerosis, osteoporosis, and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0123-0

Vitamin D and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0123-0

Normal bone anatomy and physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0123-0

Vitamin D, nervous system and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0123-0

Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0123-0

Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0123-0

Fracture history and bone loss in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0123-0

Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0123-0

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0123-0

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0123-0

Bone mineral density in ambulatory patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0123-0

Interferon-beta modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0123-0

Favorable effect of immunomodulator therapy on bone mineral density in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-012-0123-0

10.1007/S13760-012-0123-0

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference